Contineum Therapeutics, Inc. Liquidation Value
CTNM
Other
Cash & Equivalents
$75.60M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $75.60M
Total Obligations: -$17.99M
$57.61M
Per share: $24.16
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $75.60M
AR: $0
Total Obligations: -$17.99M
$57.61M
Per share: $24.16
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $75.60M
AR: $0
Inventory: $0
Total Obligations: -$17.99M
$57.61M
Per share: $24.16
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $57.61M | $24.16 |
| Liquid Liquidation Value | $57.61M | $24.16 |
| Operating Liquidation Value | $57.61M | $24.16 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $75.60M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $9.74M |
| Long-term Debt | N/A |
| Op. Lease Liability | $8.25M |
| Finance Lease | N/A |
| Shares Outstanding | 2.4M |
Explore all 153 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $75.60M | N/A | N/A | $1.02M | $9.74M | N/A | $8.25M | N/A |
| 2025-11-30 | N/A | N/A | N/A | N/A | N/A | N/A | $1.90M | N/A |
| 2025-09-30 | $42.63M | N/A | N/A | $786,000 | $6.36M | N/A | $5.49M | N/A |
| 2025-06-30 | $20.78M | N/A | N/A | $2.00M | $7.21M | N/A | $5.75M | N/A |
| 2025-03-31 | $22.47M | N/A | N/A | $3.65M | $8.95M | N/A | $6.00M | N/A |
| 2024-12-31 | $21.94M | N/A | N/A | $1.81M | $9.97M | N/A | $6.26M | N/A |
| 2024-10-01 | N/A | N/A | N/A | N/A | N/A | N/A | $5.60M | N/A |
| 2024-09-30 | $40.89M | N/A | N/A | $1.40M | $5.81M | N/A | $611,000 | N/A |
▼ Community Notes